FOR RESEARCH USE ONLY. The content provided in this article is for educational and informational purposes only and is based on published scientific literature. The compounds discussed are not approved by the FDA for human or veterinary use. They are strictly intended for laboratory research and in vitro experimentation. Pure Health Peptides does not endorse or encourage the use of these products outside of a controlled research setting.
Vilon is a synthetic dipeptide, lysine joined to glutamic acid, and one of the shortest members of the peptide-bioregulator class first described by the Khavinson research group. It is studied for a specific and unusual property for so small a molecule: sequence-specific interaction with nucleic acids.
What follows is a short tour of a very short molecule: the two-residue structure, the peptide-DNA question that defines its research class, its place among the catalog’s other bioregulators, and how each lot is verified.
Research Snapshot
- Vilon is a synthetic dipeptide composed of lysine and glutamic acid, written Lys-Glu or KE, with the molecular formula C11H21N3O5, a molecular weight of approximately 275.30 g/mol, and CAS number 45234-02-4.
- It belongs to the family of short peptide bioregulators (typically two to four residues) studied by the Khavinson group, a class examined for sequence-specific interactions with DNA in cell-based research models.
- Its research interest is as a minimal peptide, a defined two-residue sequence used to study how very short peptides interact with nucleic acids and influence gene expression in defined in vitro systems.
- In the bioregulator research toolkit, Vilon is studied alongside the longer short-peptide bioregulators in the catalog, including Prostamax (a tetrapeptide), Thymogen (a dipeptide), and Epithalon (a tetrapeptide).
- Pure Health Peptides supplies Vilon as a lyophilized Vial in 10 mg and 20 mg sizes, part of the wider catalog. Every lot is finished and tested in the US, routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics as the exclusive testing partner.
Introduction
Most of the peptides a research catalog carries are built to engage a cell-surface receptor. The short peptide bioregulators are different, and that difference is the whole reason they are studied as their own class.
These are very short sequences, often only two to four amino acids, first characterized by Vladimir Khavinson and colleagues, and the research question attached to them is not receptor binding but whether a peptide that small can interact directly with DNA and shape gene expression.
Throughout, Vilon is treated strictly as a laboratory reference material, with the findings kept in the in vitro and preclinical terms the Khavinson literature uses and no extension to applied use.
The Vilon Dipeptide
Structurally, Vilon is about as simple as a peptide gets. It is two amino acids, lysine and glutamic acid, joined by a single peptide bond, written Lys-Glu in three-letter code or KE in single-letter code.
Its molecular formula is C11H21N3O5, its molecular weight is near 275.30 g/mol, and it carries CAS number 45234-02-4.
That simplicity is the point. A dipeptide has almost no secondary structure to speak of, so any sequence-specific behavior it shows has to come from the chemistry of the two side chains themselves: the basic amino group of lysine and the acidic carboxyl of glutamic acid. Research on the Khavinson peptides proposes that these short sequences carry just enough information, in the identity and order of their residues, to interact selectively with particular stretches of DNA.
Because Vilon is a defined two-residue sequence, its identity is straightforward to confirm by mass spectrometry against its theoretical mass, which is the basis of lot-level verification.
Peptide-DNA Interaction and Gene-Expression Research
The mechanism that makes the short peptide bioregulators a distinct research class is the proposed interaction with nucleic acids.
Rather than binding a receptor on the cell surface, peptides of this class have been studied for direct, sequence-selective association with DNA, and for the regulation of gene expression that such association could influence, in cell-based study models (Fedoreyeva et al., 2011).
Work on this family describes the peptides entering cells, reaching the nucleus, and showing preferential interaction with particular oligonucleotide sequences in defined in vitro systems. Vilon, as one of the shortest members, is a useful reference point in that research because it tests the lower size limit of the idea: how much sequence-specific behavior a two-residue peptide can show.
The broader literature on the class situates these peptides in gene-regulation and bioregulation research (Anisimov and Khavinson, 2010; Khavinson, 2002). All of this is characterized in the in vitro and preclinical terms the literature uses, as molecular-interaction research rather than any applied use.
Within the catalog, Vilon’s research area spans both regeneration-and-aging and immune and inflammatory models, which is the context in which this class of short peptides is most often examined.
Vilon in the Bioregulator Research Toolkit
Vilon is most useful understood in relation to its neighbors, because the short peptide bioregulators are a coherent family studied comparatively. Prostamax is a tetrapeptide (Lys-Glu-Asp-Pro) from the same class, Thymogen is a dipeptide (Glu-Trp) studied in thymic-peptide research, and Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly) studied in pineal and telomere research. Holding these side by side lets researchers compare how sequence and length relate to the proposed peptide-DNA behavior.
Held together, these give a research program several defined entry points into the bioregulator question: a minimal dipeptide (Vilon), longer tetrapeptides (Prostamax, Epithalon), and a second dipeptide from a different tissue context (Thymogen). Vilon is the shortest reference among them, supplied as its own lyophilized vial and a distinct tool rather than a substitute for another.
Verification
Underneath the compound is the verification chain. Pure Health Peptides does not manufacture the material; production is sourced from qualified third-party manufacturers, and the material is finished and tested in the US.
Every lot is routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics as the exclusive testing partner, and each qualified lot’s Certificate of Analysis is published in the COA Library, in the vial section, retrievable by batch ID. For a lyophilized vialed peptide the appropriate panel extends beyond identity, purity, and quantity to include endotoxin and microbial limits, because contamination can enter downstream of synthesis through handling, lyophilization, vial filling, storage, and transit.
The Testing Process page documents how that verification runs, and the Manufacturing Process page covers where the material comes from.
Where Vilon Sits in Bioregulator Research
For researchers studying the short peptide bioregulators, Vilon is a specific and well-defined tool: a minimal two-residue sequence that tests how small a peptide can be and still show sequence-specific interaction with nucleic acids. Its research value rests on that minimalism, and on the comparison it enables against the longer peptides in the same class.
As research on short-peptide bioregulation continues, Vilon remains a useful reference compound, and it holds a clear place in the bioregulator cluster in the catalog.
Frequently Asked Questions
What is Vilon?
Vilon is a synthetic dipeptide, Lys-Glu (KE), from the Khavinson family of short peptide bioregulators. It has the molecular formula C11H21N3O5, a molecular weight of approximately 275.30 g/mol, and CAS number 45234-02-4. It is characterized here as a defined research reference material.
What is a peptide bioregulator?
It is a short synthetic peptide, typically two to four amino acids, from the family first described by the Khavinson research group. Research literature reports that peptides of this class are examined for sequence-specific interactions with DNA and for the regulation of gene expression in cell-based study models. These are research findings; all applications are non-clinical.
What is Vilon studied for in research?
In controlled laboratory settings it is studied as a minimal short peptide bioregulator. Research literature reports that dipeptides of this class are examined for interactions with DNA and for gene-expression regulation in in vitro models.
What are Vilon’s chemical specifications, and what size does it come in?
Vilon has the molecular formula C11H21N3O5, a molecular weight of approximately 275.30 g/mol, and CAS number 45234-02-4 (refer to the lot-specific Certificate of Analysis for the exact value). It is supplied as a lyophilized powder in 10 mg and 20 mg sizes.
What carrier format is Vilon available in, and how is it verified?
A lyophilized vial. Every lot is finished and tested in the US and routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics, with a lot-specific Certificate of Analysis published in the COA Library.
References
- Fedoreyeva LI, Kireev II, Khavinson VK, Vanyushin BF. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of peptides with deoxyribooligonucleotides and DNA. Biochemistry (Moscow), 2011;76(11):1210-1219. https://doi.org/10.1134/S0006297911110022
- Anisimov VN, Khavinson VK. Peptide bioregulation of aging: results and prospects. Biogerontology, 2010;11(2):139-149. https://doi.org/10.1007/s10522-009-9249-8
- Khavinson VK. Peptides and ageing. Neuroendocrinology Letters, 2002;23 Suppl 3:11-144. https://pubmed.ncbi.nlm.nih.gov/12374906/
- International Organization for Standardization / International Electrotechnical Commission. ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories. https://www.iso.org/standard/66912.html



